Brief: Mankind Pharma Q1 Consol Net Profit At 5.36 Billion Rupees; Ibes Profit Est. 5.77 Billion Rupees
July 31 (Reuters) - Mankind Pharma Ltd MNKI.NS :
* Q1 CONSOL NET PROFIT 5.36 BILLION RUPEES; IBES PROFIT EST. 5.77 BILLION
RUPEES
* Q1 CONSOL REVENUE FROM OPERATIONS 28.93 BILLION RUPEES; IBES EST. 29.48
BILLION
RUPEES
Further company coverage: MNKI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery